Parkinson's Disease

(asked on 29th March 2018) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how much has been spent from the public purse on the prescription of drugs to manage Parkinson's disease in each of the last five years.


Answered by
Steve Brine Portrait
Steve Brine
This question was answered on 17th April 2018

The Net Ingredient Cost of drugs prescribed and dispensed in primary care under British National Formulary (BNF) section 4.9: Drugs used in parkinsonism and related disorders, split by BNF paragraph for each of the last five years is as follows:

Year

BNF 4.9: Drugs used in parkinsonism and related disorders (£s)

of which

BNF 4.9.1: Dopaminergic drugs used in parkinson’s (£s)

BNF 4.9.2: Antimuscarinic drugs used in parkinsonism (£s)

BNF 4.9.3: Essential tremor, chorea, tics and related disorders (£s)

2013

104,719,789

94,581,427

5,804,699

4,333,662

2014

105,832,050

96,847,914

6,015,487

2,968,648

2015

111,693,675

101,840,937

7,230,887

2,621,851

2016

122,804,497

103,428,224

16,917,632

2,458,641

2017

114,045,034

99,357,663

12,343,515

2,343,856

Source: Prescription Cost Analysis

Reticulating Splines